NMPA Ta Amince Da Sabon Maganin Disitamab Vedotin A Cikin Ciwon Nono Mai Rahusa Na HER2 Tare Da Ciwon Hanta

Kwanan nan, Hukumar Kula da Kayayyakin Lafiya ta Ƙasa (NMPA) ta amince da wani sabon tsari na maganin antibody-drug conjugate (ADC) Disitamab vedotin don maganin manya marasa lafiya da ke fama da cutar kansar nono waɗanda ba za a iya cirewa ko kuma suka kamu da cutar ba (IHC 1+ ko IHC 2+/ISH-) da kuma metastases na hanta, waɗanda a baya suka sami aƙalla magani ɗaya a cikin yanayin metastatic, ko kuma suka sake komawa ciki a cikin ko cikin watanni 12 bayan kammala maganin adjuvant chemotherapy.

Wannan shi ne karo na huɗu da aka amince da shi wajen amfani da Disitamab vedotin a China, bayan amincewar da aka yi a baya kan cutar kansar ciki, cutar kansar urothelial, da kuma cutar kansar nono mai kama da HER2-positive tare da cutar hanta.

Shaidar asibiti da ke goyon bayan wannan sabon nuni ta dogara ne akan gwajin asibiti na Phase III mai tsari da aka yi bazuwar, wanda aka yi a layi ɗaya, wanda aka sarrafa shi daidai gwargwado, wanda aka gudanar a China (RC48-C012). Binciken ya nuna inganci da amincin Disitamab vedotin wajen magance manyan marasa lafiya da ke fama da ciwon nono waɗanda ba za a iya cirewa ko kuma waɗanda suka kamu da cutar ba (IHC 1+ ko IHC 2+/ISH-) da kuma waɗanda suka kamu da cutar hanta, waɗanda a baya suka sami aƙalla magani ɗaya na tsarin a yanayin da ba a taɓa samun cutar ba, ko kuma suka sake komawa ciki a cikin ko cikin watanni 12 bayan kammala maganin chemotherapy na adjuvant.

Idan kai ko ɗan uwanka kuna fuskantar irin wannan ganewar asali kuma kuna son sanin sabbin hanyoyin magani, Sashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing ya sadaukar da kai don samar wa marasa lafiya na duniya ayyukan likitanci na zamani da kulawa mai fannoni daban-daban waɗanda suka dace da ƙa'idodin ƙasashen duniya. Ƙungiyarmu za ta iya taimaka muku wajen samun hanyoyin magani na zamani da kuma haɗuwa da manyan ƙwararru, don tabbatar da ƙwarewar likita ta ƙwararru, mai dacewa, da kuma ta musamman a China.

**Tuntube mu a yau don fara tafiyarku ta murmurewa da shawarwari:**
- **Layin Sadarwa:** 400-880-3716 (akwai a kowane lokaci 24/7)
- **WeChat:** 17801183037 (ƙara mana don sadarwa nan take)
- **Imel:**
- 100085_010@163.com
- myimmnet@163.com

Ko ina kake, Sashen Duniya na Asibitin Oncology na Yankin Kudu na Beijing yana aiki a matsayin gada mai ƙarfi a gare ku don samun ingantattun albarkatun kiwon lafiya a kan iyakoki. Bari mu yi aiki tare don mayar da ci gaban kiwon lafiya na zamani zuwa sabon bege ga rayuwarku.